Join to view full profile
200 Hawkins DrIowa City, IA 52242
Phone+1 319-356-2075
Fax+1 319-353-8383
Dr. Abu Hejleh is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Iowa Health Care Medical CenterFellowship, Hematology and Medical Oncology, 2009 - 2012- University of Iowa Health Care Medical CenterResidency, Internal Medicine, 2006 - 2009
Jordan University of Science and Technology FOMClass of 2004
Certifications & Licensure
IA State Medical License 2006 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2014-2016
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014-2016
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2014-2016
Clinical Trials
- Use Peripheral Blood Proteomics to Predict the Treatment Response and Toxicities in NSCLC Immunotherapy Start of enrollment: 2019 Apr 15
Roles: Sponsor-Investigator, Principal Investigator, Contact
Publications & Presentations
PubMed
- 6 citationsImpact of the Immediate Release of Clinical Information Rules on Health Care Delivery to Patients With Cancer.P Abena Anyidoho, Claire F Verschraegen, Merry Jennifer Markham, Steven Alberts, John Sweetenham
JCO Oncology Practice. 2023-05-01 - 3 citationsA Phase II Trial of Atezolizumab Plus Carboplatin Plus Pemetrexed Plus Bevacizumab in the Treatment of Patients with Stage IV Non-Squamous Non-Small Cell Lung Cancer: ...Fatemeh Ardeshir-Larijani, Sandra K Althouse, Ticiana Leal, Lawrence Eric Feldman, Taher Abu Hejleh
Clinical Lung Cancer. 2022-11-01 - 7 citationsSuccessful response to first-line treatment with osimertinib for choroidal metastasis from EGFR-mutated non-small-cell lung cancer.Matthew G Field, H Culver Boldt, Taher Abu Hejleh, Elaine M Binkley
American Journal of Ophthalmology Case Reports. 2022-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
